This document is a published patent application from the USPTO, not a regulatory rule or guidance. It describes a novel method and composition for reducing blood lipids in mammals using specific plant extracts, Dichrostachys glomerata or Cissus quadrangularis. The application details potential health benefits, including increased GLP-1 levels and reduced visceral fat, food intake, blood lipids, total cholesterol, and total glucose. The filing date was September 26, 2024, and the publication date is March 26, 2026.

As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it may be of interest to pharmaceutical and drug manufacturers researching new therapeutic compounds. Companies involved in the development or commercialization of such treatments should monitor the patent's progress and consider its implications for their intellectual property and product development strategies.